This module provides an online competency assessment for the classification of BRCA and HRR (Homologous Recombination Repair) gene variants.
All individuals who classify the pathogenicity of BRCA and other HRR gene variants.
For each assessment, participants receive 6 variants to classify within 4 weeks. Participants can choose to classify some or all of the variants. For each variant classification submitted, participants should also provide the criteria evidence for their classification.
All participants will receive the following:
For further information please contact us at info@genqa.org
Available globally
Participate multiple times throughout the year
Participant tailored assessment
Complete within 4 weeks
Access your EQA record any time through the GenQA website
Run 13 is no longer available for enrolment
This educational content was co-developed and funded by AstraZeneca and MSD. The authors, reviewers, and editors of this material have made extensive efforts to ensure that the information is accurate and conforms to the standards accepted at the time of publication. However, constant changes in information resulting from continuing research and clinical experience, reasonable differences in opinions among authorities, unique aspects of individual clinical situations, and the possibility of human error in preparing materials mean that other sources of medical information may differ from the information on this site. The reader is advised to also consult local medical sources.
Z4-63360; Date of preparation: April 2024
NEWSLETTER SIGN UP